Resignation of Director
Jubilant Life Sciences Ltd has informed BSE that Mr. Shardul S. Shroff, Independent Director has resigned from the Board of Directors of the Company effective from May 24, 2016.24-05-2016
24-05-2016
Board recommends Dividend
Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2016, has recommended a dividend of Rs. 3 (Rupees Three) per equity share of Re. 1 each for the year ended March 31, 2016. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before September 28, 2016.24-05-2016
Announces Q4 & FY16 Results (Standalone & Consolidated), Form A (Standalone & Consolidated), Auditors Report (Standalone & Consolidated), Results Press Release & Presentation for the period ended March 31, 2016
Jubilant Life Sciences Ltd has announced the following results for the quarter & year ended March 31, 2016"The Audited Standalone results for the Quarter ended March 31, 2016The Company has posted a net loss of Rs. (74.70) million for the quarter ended March 31, 2016 where as the same was at net loss of Rs. (2068.90) million for the quarter ended March 31, 2015. Total Income is Rs. 6367.00 million for the quarter ended March 31, 2016...24-05-2016
Jubilant Lifesciences gains as company calls off deal with Cyclopharm
Shares of Jubilant Life Sciences surged 4 per cent in Thursday's trade after the company its wholly-owned subsidiary and Australia-based Cyclopharm mutually called off their previously announced term sheet for exclusive commercial rights for Technegas in the US market.12-05-2016
Jubilant and Cyclopharm mutually agree to terminate term sheet for Technegas licensing agreement
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated May 11, 2016 titled "Jubilant and Cyclopharm mutually agree to terminate term sheet for Technegas licensing agreement".11-05-2016
Schedule of Investor Conference Call
Jubilant Life Sciences Ltd has informed BSE regarding "Schedule of Investor Conference Call".10-05-2016
FY16 results on May 24, 2016
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 24, 2016, inter alia, to consider:1. Audited Financial Results of the Company for the year ended March 31, 2016;2. Recommendation of Dividend for the year ended March 31, 2016.Further, as per the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities...10-05-2016
Intimation of Schedule of Investor / Analyst Meetings
Jubilant Life Sciences Ltd has informed BSE regarding "Intimation of Schedule of Investor / Analyst Meetings".09-05-2016
Newspapar advertisement for Postal Ballot
Jubilant Life Sciences Ltd has submitted to BSE copies of the advertisement published on April 30, 2016, with respect to completion of despatch of notices of Postal Ballot.02-05-2016